Bone Marrow Stromal Cell Antigen 2 (BST2) (N-Term) Peptide
Quick Overview for Bone Marrow Stromal Cell Antigen 2 (BST2) (N-Term) Peptide (ABIN973910)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- RVPMEDGDKR CKLLLGIGIL VLLIIVILGV PLIIFTIKAN SEACRDGLRA
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-BST2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BST2 (Bone Marrow Stromal Cell Antigen 2 (BST2))
-
Background
-
Bone marrow stromal cells are involved in the growth and development of B-cells. The specific function of the protein encoded by the bone marrow stromal cell antigen 2 is undetermined, however, this protein may play a role in pre-B-cell growth and in rheumatoid arthritis.
Alias Symbols: CD317, TETHERIN
Protein Interaction Partner: vpu
Protein Size: 180 -
Molecular Weight
- 20 kDa
-
Gene ID
- 684
-
NCBI Accession
- NM_004335, NP_004326
-
UniProt
- Q10589
Target
-